pubmed-article:11294919 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11294919 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11294919 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:11294919 | lifeskim:mentions | umls-concept:C0002736 | lld:lifeskim |
pubmed-article:11294919 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:11294919 | lifeskim:mentions | umls-concept:C0060926 | lld:lifeskim |
pubmed-article:11294919 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:11294919 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:11294919 | pubmed:dateCreated | 2001-4-11 | lld:pubmed |
pubmed-article:11294919 | pubmed:abstractText | Preclinical and clinical studies of gabapentin in patients with ALS led the authors to undertake a phase III randomized clinical trial. | lld:pubmed |
pubmed-article:11294919 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:language | eng | lld:pubmed |
pubmed-article:11294919 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11294919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11294919 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11294919 | pubmed:month | Apr | lld:pubmed |
pubmed-article:11294919 | pubmed:issn | 0028-3878 | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:MillerR GRG | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:JohnsonWW | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:YuenEE | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:SmithBB | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:GravesMM | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:JacksonCC | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:NevilleHH | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:RossMM | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:MendozaMM | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:ParryGG | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:MooreD HDH2nd | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:BryanWW | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:MandlerRR | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:BrombergMM | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:RingelSS | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:BoscoII | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:OlneyRR | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:BarohnR JRJ | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:GelinasD FDF | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:RavitsJJ | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:PetajanJJ | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:SorensonE JEJ | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:AmatoA AAA | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:KelkarPP | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:DronskyVV | lld:pubmed |
pubmed-article:11294919 | pubmed:author | pubmed-author:Western ALS... | lld:pubmed |
pubmed-article:11294919 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11294919 | pubmed:day | 10 | lld:pubmed |
pubmed-article:11294919 | pubmed:volume | 56 | lld:pubmed |
pubmed-article:11294919 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11294919 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11294919 | pubmed:pagination | 843-8 | lld:pubmed |
pubmed-article:11294919 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:meshHeading | pubmed-meshheading:11294919... | lld:pubmed |
pubmed-article:11294919 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11294919 | pubmed:articleTitle | Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. | lld:pubmed |
pubmed-article:11294919 | pubmed:affiliation | Department of Neurology, California Pacific Medical Center, San Francisco, USA. rmiller@cooper.cpmc.org | lld:pubmed |
pubmed-article:11294919 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11294919 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11294919 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:11294919 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:11294919 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:11294919 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11294919 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11294919 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11294919 | lld:pubmed |